This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to utilization increases, not price.
William A. Sarraille, JD
Advertisement
William A. Sarraille JD, is Professor of Practice, University of Maryland Francis King Carey School of Law.
ORCID ID: 0009-0008-0593-0473
Articles by William A. Sarraille, JD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently
2
Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains
3
Defunding Co-Payment Assistance Disrupted nAMD Care
4
Study Finds Flaw in Method for Key Oncology Value-Based Care Model
5